Artificial Virus Delivers CRISPR-Cas9 System for Genome Editing of Cells in Mice

Cited by (245)

Items 101–200 of 245

1. CRISPR/Cas9 delivery by NIR-responsive biomimetic nanoparticles for targeted HBV therapy
   Dan Wang, Ling Chen, Li Chengbi, Quanxin Long, Qing Yang, Ailong Huang, Hua Tang · 2022 · Journal of Nanobiotechnology
2. A multifunctional non-viral vector for the delivery of MTH1-targeted CRISPR/Cas9 system for non-small cell lung cancer therapy
   Yu Wang, Yan Xue Tang, Xiaomei Zhao, Gui Huang, Jinhong Gong, Shu-di Yang, Hui zi Li, Wenjun Wan, Changhao Jia, Gang Chen et al. · 2022 · Acta Biomaterialia
3. Statistical versus block fluoropolymers in gene delivery
   Echuan Tan, Jia Lv, Jingjing Hu, Wanwan Shen, Hui Wang, Yiyun Cheng · 2018 · Journal of Materials Chemistry B
4. Knockdown of SNHG12 suppresses tumor metastasis and epithelial‑mesenchymal transition via the Slug/ZEB2 signaling pathway by targeting miR‑218 in NSCLC
   Yan Wang, Shuxin Liang, Yang Yu, Yankui Shi, Hailiang Zheng · 2018 · Oncology Letters
5. CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
   Xiaoping Zhang, Xu Chen, Shijuan Gao, Ping Li, Yu Kong, Tiantian Li, Yulin Li, Fu‐Jian Xu, Jie Du · 2019 · Advanced Science
6. Chain-shattering Pt(IV)-backboned polymeric nanoplatform for efficient CRISPR/Cas9 gene editing to enhance synergistic cancer therapy
   Qingfei Zhang, Gaizhen Kuang, Shasha He, Sha Liu, Hongtong Lu, Xiaoyuan Li, Dongfang Zhou, Yubin Huang · 2020 · Nano Research
7. Reduction‐Sensitive Fluorinated‐Pt(IV) Universal Transfection Nanoplatform Facilitating CT45‐Targeted CRISPR/dCas9 Activation for Synergistic and Individualized Treatment of Ovarian Cancer
   Hongtong Lu, Qingfei Zhang, Shasha He, Sha Liu, Zhigang Xie, Xiaoyuan Li, Yubin Huang · 2021 · Small
8. Combined intramyocardial injectable hydrogel and pericardial adhesive hydrogel patch therapy strategy to achieve gene/ion/gas delivery for improving cardiac function
   Xiaoping Zhang, Yage Sun, Tengling Wu, Xinrui Zhao, Rong Yang, Hongying Wang, Wenguang Liu · 2023 · Nano Today
9. Fragment-Based Discovery and Optimization of Enzyme Inhibitors by Docking of Commercial Chemical Space
   Axel Rudling, Robert Gustafsson, Ingrid Almlöf, Evert J. Homan, Martin Scobie, Ulrika Warpman Berglund, Thomas Helleday, Pål Stenmark, Jens Carlsson · 2017 · Journal of Medicinal Chemistry
10. Nano-vectors for CRISPR/Cas9-mediated genome editing
    Peng Yang, Athena Yue-Tung Lee, Jingjing Xue, Shih‐Jie Chou, Calvin Lee, Patrick Tseng, Tiffany X. Zhang, Yazhen Zhu, Junseok Lee, Shih‐Hwa Chiou et al. · 2022 · Nano Today
11. Fluorinated DNA Micelles: Synthesis and Properties
    Jianmei Zou, Cheng Yu Jin, Ruowen Wang, Hailan Kuai, Lili Zhang, Xiaobing Zhang, Juan Li, Liping Qiu, Weihong Tan · 2018 · Analytical Chemistry
12. Improving the knock-in efficiency of the MOF-encapsulated CRISPR/Cas9 system through controllable embedding structures
    Chang Liu, Xiaoyu Xu, Oliver Koivisto, Wenhui Zhou, Guillaume Jacquemet, Jessica M. Rosenholm, Hongbo Zhang · 2021 · Nanoscale
13. Bioorthogonal Reaction‐Mediated Tumor‐Selective Delivery of CRISPR/Cas9 System for Dual‐Targeted Cancer Immunotherapy
    Jingjing Yang, Kaiyong Yang, Shiyu Du, Wen Luo, Chao Wang, Hongmei Liu, Kunguo Liu, Zhibin Zhang, Yanfeng Gao, Xin Han et al. · 2023 · Angewandte Chemie International Edition
14. Potent and specific MTH1 inhibitors targeting gastric cancer
    Wenjuan Zhou, Liying Ma, Jing Chun Yang, Hui Qiao, Lingyu Li, Qian Guo, Jinlian Ma, Lijuan Zhao, Junwei Wang, Guozhong Jiang et al. · 2019 · Cell Death and Disease
15. A Genome-Editing Nanomachine Constructed with a Clustered Regularly Interspaced Short Palindromic Repeats System and Activated by Near-Infrared Illumination
    Hanyong Peng, Connie Le, Jinjun Wu, Xing‐Fang Li, Hongquan Zhang, X. Chris Le · 2020 · ACS Nano
16. Delivery of CRISPR/Cas9 Plasmids by Cationic Gold Nanorods: Impact of the Aspect Ratio on Genome Editing and Treatment of Hepatic Fibrosis
    Yuxuan Chen, Xiaohong Chen, Di Wu, Huhu Xin, Desui Chen, Da Li, Hongming Pan, Chang‐Xin Zhou, Ping Yuan · 2020 · Chemistry of Materials
17. Charge-reversal nanocomolexes-based CRISPR/Cas9 delivery system for loss-of-function oncogene editing in hepatocellular carcinoma
    Jing‐Jun Nie, Yanli Liu, Qi Yu, Nasha Zhang, Bingran Yu, Dafu Chen, Ming Yang, Fu‐Jian Xu · 2021 · Journal of Controlled Release
18. Advancements in CRISPR/Cas systems for disease treatment
    Yangsong Xu, Hao Le, Qinjie Wu, Ning Wang, Changyang Gong · 2025 · Acta Pharmaceutica Sinica B
19. Genome editing mRNA nanotherapies inhibit cervical cancer progression and regulate the immunosuppressive microenvironment for adoptive T-cell therapy
    Kaijian Ling, Yin Dou, Neng Yang, Li Deng, Yanzhou Wang, Yudi Li, Leiyan Yang, Cheng Chen, Lupin Jiang, Qingchun Deng et al. · 2023 · Journal of Controlled Release
20. Synthesis of indocyanine green functionalized comblike poly(aspartic acid) derivatives for enhanced cancer cell ablation by targeting the endoplasmic reticulum
    Jiaxun Wan, Luyan Sun, Pan Wu, Fang Wang, Jia Guo, Jianjun Cheng, Changchun Wang · 2018 · Polymer Chemistry
21. In Vivo Tracking of Fluorinated Polypeptide Gene Carriers by Positron Emission Tomography Imaging
    Xinyu Wang, Guangyu Rong, Junjie Yan, Donghui Pan, Lizhen Wang, Yuping Xu, Min Yang, Yiyun Cheng · 2020 · ACS Applied Materials & Interfaces
22. A fluorinated peptide with high serum- and lipid-tolerence for the delivery of siRNA drugs to treat obesity and metabolic dysfunction
    Jin Qiu, Qianqian Fan, Sainan Xu, Dongmei Wang, Juntong Chen, Sainan Wang, Tianhui Hu, Xinran Ma, Yiyun Cheng, Lingyan Xu · 2022 · Biomaterials
23. Pre-clinical non-viral vectors exploited for in vivo CRISPR/Cas9 gene editing: an overview
    Nadia Rouatbi, Tasneem McGlynn, Khuloud T. Al‐Jamal · 2022 · Biomaterials Science
24. Application of Nanoparticle-Based siRNA and CRISPR/Cas9 Delivery Systems in Gene-Targeted Therapy
    Yingkai Tao, Xiaoyang Hou, Fengmei Zuo, Xinxin Li, Yanyu Pang, Guan Jiang · 2019 · Nanomedicine
25. Mutation-Directed Therapeutics for Neurofibromatosis Type I
    André Leier, David M. Bedwell, Ann T. Chen, George Dickson, Kim M. Keeling, Robert A. Kesterson, Bruce R. Korf, Tatiana T. Marquez‐Lago, Ulrich F. Müller, Linda J. Popplewell et al. · 2020 · Molecular Therapy — Nucleic Acids
26. Non-viral nanocarriers for CRISPR-Cas9 gene editing system delivery
    Xuefeng Tang, Zhao Wang, Ying Zhang, Wei Mu, Xiaojun Han · 2022 · Chemical Engineering Journal
27. Nanotechnology‐based CRISPR/Cas9 delivery system for genome editing in cancer treatment
    Shiyao Zhou, Yingjie Li, Qinjie Wu, Changyang Gong · 2024 · MedComm – Biomaterials and Applications
28. Nonviral Nanoparticles for CRISPR-Based Genome Editing: Is It Just a Simple Adaption of What Have Been Developed for Nucleic Acid Delivery?
    Min Qiu, Zachary Glass, Qiaobing Xu · 2019 · Biomacromolecules
29. Smart Strategies for Precise Delivery of CRISPR/Cas9 in Genome Editing
    Akbar Hasanzadeh, Hamid Noori, Atefeh Jahandideh, Niloofar Haeri Moghaddam, Seyede Mahtab Kamrani Mousavi, Helena Nourizadeh, Sara Saeedi, Mahdi Karimi, Michael Richard Hamblin · 2022 · ACS Applied Bio Materials
30. Tumor Microenvironment‐Responsive Nanocapsule Delivery CRISPR/Cas9 to Reprogram the Immunosuppressive Microenvironment in Hepatoma Carcinoma
    Lei He, Zhaozhao Li, Danjie Su, Haichen Du, Kuo Zhang, Wangqian Zhang, Shuning Wang, Fei Xie, Yueyuan Qiu, Shuangxin Ma et al. · 2024 · Advanced Science
31. Polyethylenimine-Functionalized Carbon Dots for Delivery of CRISPR/Cas9 Complexes
    Iman Hashemzadeh, Akbar Hasanzadeh, Fatemeh Radmanesh, Beheshteh Khodadadi Chegeni, Elaheh Sadat Hosseini, Jafar Kiani, Ali Shahbazi, Marzieh Naseri, Yousef Fatahi, Helena Nourizadeh et al. · 2021 · ACS Applied Bio Materials
32. Synergy of nanocarriers with CRISPR-Cas9 in an emerging technology platform for biomedical appliances: Current insights and perspectives
    Rahul Bhattacharjee, Ankit Jana, Aditya Nandi, Adrija Sinha, Arkadyuti Bhattacharjee, Sagnik Mitra, Sulagna Kar, Abhijit Dey, Sushil Kumar Singh, Rajender S. Varma et al. · 2022 · Materials & Design
33. CRISPR/Cas9 Technology as an Emerging Tool for Targeting Amyotrophic Lateral Sclerosis (ALS)
    Ewa Kruminis-Kaszkiel, Judyta Karolina Juranek, Wojciech Maksymowicz, Joanna Wojtkiewicz · 2018 · International Journal of Molecular Sciences
34. The evolution and history of gene editing technologies
    Shubhchintan Randhawa, Shatakshi Sengar · 2021 · Progress in molecular biology and translational science
35. Genome Editing in a Wide Area of the Brain Using Dendrimer-Based Ternary Polyplexes of Cas9 Ribonucleoprotein
    Toru Taharabaru, Ryoma Yokoyama, Taishi Higashi, Ahmed Fouad Abdelwahab Mohammed, Masamichi Inoue, Yuki K. Maeda, Takuro Niidome, Risako Onodera, Keiichi Motoyama · 2020 · ACS Applied Materials & Interfaces
36. Highly Photoluminescent Nitrogen- and Zinc-Doped Carbon Dots for Efficient Delivery of CRISPR/Cas9 and mRNA
    Akbar Hasanzadeh, Fatemeh Radmanesh, Elaheh Sadat Hosseini, Iman Hashemzadeh, Jafar Kiani, Helena Nourizadeh, Marzieh Naseri, Yousef Fatahi, Fateme Chegini, Zahra Madjd et al. · 2021 · Bioconjugate Chemistry
37. Recent advances in stimuli-responsive polymeric carriers for controllable CRISPR/Cas9 gene editing system delivery
    Panqin Ma, Qi Wang, Xi Luo, Liuzhou Mao, Zhanxiang Wang, Enyi Ye, Xian Jun Loh, Zibiao Li, Yun‐Long Wu · 2023 · Biomaterials Science
38. A General and Efficient Strategy for Gene Delivery Based on Tea Polyphenols Intercalation and Self‐Polymerization
    Chen, Hao, Guo, Lina, Ding, Jinsong, Zhou, Wenhu, Qi, Yan · 2023 · Advanced Science
39. Innovative Precision Gene‐Editing Tools in Personalized Cancer Medicine
    Xiaofeng Dai, Pilar Blancafort, Peiyu Wang, Agustin Sgro, Erik W. Thompson, Kostya Ostrikov · 2020 · Advanced Science
40. CRISPR-Cas9 in Alzheimer’s disease: Therapeutic trends, modalities, and challenges
    Leena Chacko, Anupama Chaudhary, Birbal Singh, Saikat Dewanjee, Ramesh J. L. Kandimalla · 2023 · Drug Discovery Today
41. Lipid and polymer mediated CRISPR/Cas9 gene editing
    Yan Gong, Siyu Tian, Xuan Yang, Shubiao Zhang · 2020 · Journal of Materials Chemistry B
42. Karonudib is a promising anticancer therapy in hepatocellular carcinoma
    Xiangwei Hua, Kumar Sanjiv, Helge Gad, Therese M. Pham, Camilla Göktürk, Azita Rasti, Zhenjun Zhao, Kang He, Mingxuan Feng, Yunjin Zang et al. · 2019 · Therapeutic Advances in Medical Oncology
43. A programmable hierarchical-responsive nanoCRISPR elicits robust activation of endogenous target to treat cancer
    Chao Liu, Ning Wang, Rui Luo, Lu Li, Wen Yang, Xiye Wang, Meiling Shen, Qinjie Wu, Changyang Gong · 2021 · Theranostics
44. Farnesyl phenolic enantiomers as natural MTH1 inhibitors from Ganoderma sinense
    Ya Gao, Lihan Zhu, Jing Guo, Ting Yuan, Liqing Wang, Hua Li, Lixia Chen · 2017 · Oncotarget
45. Cationic polymeric nanoformulation: Recent advances in material design for CRISPR/Cas9 gene therapy
    Kaifeng Chen, Shan Jiang, Yun Yu Hong, Zibiao Li, Yun‐Long Wu, Caisheng Wu · 2019 · Progress in Natural Science Materials International
46. Rational Molecular Engineering of Organic Semiconducting Nanoplatforms for Advancing NIR‐II Fluorescence Theranostics
    Xiaoming Hu, Zejing Chen, Haiyong Ao, Quli Fan, Zhèn Yáng, Wei Huang · 2022 · Advanced Optical Materials
47. Spatiotemporal Delivery of CRISPR/Cas9 Genome Editing Machinery Using Stimuli‐Responsive Vehicles
    Weiqi Cai, Tianli Luo, Lanqun Mao, Ming Wang · 2020 · Angewandte Chemie
48. Reversal of tumor malignization and modulation of cell behaviors through genome editing mediated by a multi-functional nanovector
    Boya Liu, Xiaoyan He, Ren‐Xi Zhuo, Si‐Xue Cheng · 2018 · Nanoscale
49. Multivalent Peptide-Functionalized Bioreducible Polymers for Cellular Delivery of Various RNAs
    Dong‐Chu Yang, Alexander C. Eldredge, James C. Hickey, Hurik Muradyan, Zhibin Guan · 2020 · Biomacromolecules
50. Facile Preparation of Polysaccharide−Polypeptide Conjugates via a Biphasic Solution Ring-Opening Polymerization
    Fangping Yang, Zhiwei Liu, Wenting Si, Ziyuan Song, Lichen Yin, Haoyu Tang · 2022 · ACS Macro Letters
51. Understanding the Potential of Genome Editing in Parkinson’s Disease
    David Arango, Amaury Bittar, Natalia P. Esmeral, Camila Ocasión, Carolina Muñoz-Camargo, Juan C. Cruz, Luis H. Reyes, Natasha I. Bloch · 2021 · International Journal of Molecular Sciences
52. Novel Approaches for the Treatment of Familial Hypercholesterolemia: Current Status and Future Challenges
    Long Jiang, Luya Wang, Xiaoshu Cheng · 2018 · Journal of Atherosclerosis and Thrombosis
53. Fluorocarbons Enhance Intracellular Delivery of Short STAT3-sensors and Enable Specific Imaging
    Valeri Metelev, Surong Zhang, Shaokuan Zheng, Anand T. N. Kumar, Alexei A. Bogdanov Jr · 2017 · Theranostics
54. Toward the Treatment of Inherited Diseases of the Retina Using CRISPR-Based Gene Editing
    Jennifer Hernández-Juárez, Genaro Rodríguez‐Uribe, Shyamanga Borooah · 2021 · Frontiers in Medicine
55. CRISPR/Cas9-based genome editing for multimodal synergistic cancer nanotherapy
    Yinying Pu, Wencheng Wu, Huijing Xiang, Yu Chen, Huixiong Xu · 2022 · Nano Today
56. Possible therapeutic targets for NLRP3 inflammasome-induced breast cancer
    Xixi Wang, Junyi Lin, Zhe Wang, Zhi Li, Minghua Wang · 2023 · Discover Oncology
57. Smart arginine-equipped polycationic nanoparticles for p/CRISPR delivery into cells
    Pardis Moradi, Akbar Hasanzadeh, Fatemeh Radmanesh, Saideh Rajai‐Daryasarei, Elaheh Sadat Hosseini, Jafar Kiani, Ali Shahbazi, Helena Nourizadeh, Maryam Eslami, Akbar Dorgalaleh et al. · 2021 · Nanotechnology
58. Current Status of Nonviral Vectors for Gene Therapy in China
    Li Liu, H. J. Yang, Ke Men, Zhiyao He, Min Luo, Zhiyong Qian, Xiawei Wei, Yuquan Wei · 2018 · Human Gene Therapy
59. Copper ionophore-autophagy interference nanoregulators for tumor self-defense reprograming to amplify cuproptotic stress and antitumor immunity
    Enze Li, Liewei Wen, Caiyun Yin, Nan Wang, Suleixin Yang, Wenzheng Feng, Meiwan Chen · 2025 · Journal of Controlled Release
60. Natural Biopolymer-Based Delivery of CRISPR/Cas9 for Cancer Treatment
    Meng Lin, Xueyan Wang · 2023 · Pharmaceutics
61. 多样化CRISPR技术在动物体内基因编辑研究中的应用和进展
    马迅, Xun Ma, 黄芯渝, 谭晞彦, 崔雍建, 钟礼瞬, 冯波, Avery Sum-Yu Wong, Hei-Yin Tam, Samuel Yung-Kin Tsui et al. · 2018 · 动物学研究
62. Fluorinated vectors for gene delivery
    Yu Wan, Yuhan Yang, Mingyu Wu, Shun Feng · 2022 · Expert Opinion on Drug Delivery
63. MTH1 promotes mitotic progression to avoid oxidative DNA damage in cancer cells
    Helge Gad, Oliver Mortusewicz, Sean G. Rudd, Ailine Stolz, Nuno Amaral, Lars Brautigham, Linda Pudelko, Kumar Sanjiv, Christina Kalderén, Ann‐Sofie Jemth et al. · 2019 · bioRxiv (Cold Spring Harbor Laboratory)
64. Tailoring non-viral delivery vehicles for transporting genome-editing tools
    Wujin Sun, Zhen Gu · 2016 · Science China Materials
65. Magnetic‐Activated Nanosystem with Liver‐Specific CRISPR Nonviral Vector to Achieve Spatiotemporal Liver Genome Editing as Hepatitis B Therapeutics
    Chenya Zhuo, Huiming Kong, Ke Yi, Chun‐Wei Chi, Jiabin Zhang, Ran Chen, Haixia Wang, Caixia Wu, Yeh‐Hsing Lao, Yu Tao et al. · 2023 · Advanced Functional Materials
66. Hierarchical-unlocking virus-esque NanoCRISPR precisely disrupts autocrine and paracrine pathway of VEGF for tumor inhibition and antiangiogenesis
    Shuang Ma, Yingjie Li, Furong Liu, Xinxin Wang, Zeyi Qin, Li Wang, Jin Ping Yang, Li Wang, Wen Yang, Ning Wang et al. · 2024 · Journal of Controlled Release
67. A hierarchical assembly strategy to engineer dextran-enveloped polyurethane nanopolyplexes for robust ovarian cancer gene therapy
    Bo Lou, Rong Jin, Jian Cheng, Xuejun Wen, Peng Zhao, Chao Lin · 2018 · Acta Biomaterialia
68. CRISPR delivery systems for organ-specific targeting: Advances and challenges
    Jun Du, Qinjie Wu, Chao Liu, Ning Wang, Changyang Gong · 2025 · Precision medicine and engineering.
69. Supramolecular Nanosubstrate‐Mediated Delivery for CRISPR/Cas9 Gene Disruption and Deletion
    Qian Ban, Peng Yang, Shih‐Jie Chou, Li Qiao, Haidong Xia, Jingjing Xue, Fang Wang, Xiaobin Xu, Na Sun, Ryan Y. Zhang et al. · 2021 · Small
70. Fluoropolymers-mediated efficient biomacromolecule drug delivery
    Tingting Song, Yuemei Gao, Mingjie Song, Qian Jia, Huaqing Zhang, Jianping Zhou, Yang Ding · 2022 · Medicine in Drug Discovery
71. CRISPR/Cas9-mediated activation of CDH1 suppresses metastasis of breast cancer in rats
    Fatma A. Al-Mulhim, Amany I. Alqosaibi, Afnan Al-Muhnna, Khalid Farid, Shaimaa E. Abdel-Ghany, Hamdy Rizk, Abdelbary Mohammed Prince, Adaugo C. Isichei, Hussein Sabit · 2021 · Electronic Journal of Biotechnology
72. Nanoparticles‐Mediated CRISPR/Cas Gene Editing Delivery System
    Phei Er Saw, Guo‐hui Cui, Xiaoding Xu · 2022 · ChemMedChem
73. Tumor microenvironment based stimuli-responsive CRISPR/Cas delivery systems: A viable platform for interventional approaches
    Nanyang Tang, Qian Ning, Zewei Wang, Yifang Tao, Xuhong Zhao, Shengsong Tang · 2021 · Colloids and Surfaces B Biointerfaces
74. Multi-level ROS regulation to activate innate and adaptive immune therapies
    Ke-Ke Feng, Cheng-Lei Li, Yifan Tu, Shi-Cheng Tian, Rui Xiong, Baisheng Sa, Jingwei Shao · 2025 · Chemical Engineering Journal
75. Crystal Structures and Inhibitor Interactions of Mouse and Dog MTH1 Reveal Species-Specific Differences in Affinity
    Mohit Narwal, Ann‐Sofie Jemth, Robert Gustafsson, Ingrid Almlöf, Ulrika Warpman Berglund, Thomas Helleday, Pål Stenmark · 2017 · Biochemistry
76. Dual-targeting nanoparticles with excellent gene transfection efficiency for gene therapy of peritoneal metastasis of colorectal cancer
    Ling Li, Rui Deng, Yi Su, Cheng Yang · 2017 · Oncotarget
77. Hierarchically tumor-activated nanoCRISPR-Cas13a facilitates efficient microRNA disruption for multi-pathway-mediated tumor suppression
    Xiaowei Liu, Suleixin Yang, Li Wang, Xinyue Wu, Xinxin Wang, Chunqing Ou, Jin Ping Yang, Linjiang Song, Shiyao Zhou, Qinjie Wu et al. · 2023 · Theranostics
78. CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment
    Siddhant Tripathi, Yashika Sharma, Rajesh A. Rane, Dileep Kumar · 2024 · CNS & Neurological Disorders - Drug Targets
79. Brain‐Targeted Cas12a Ribonucleoprotein Nanocapsules Enable Synergetic Gene Co‐Editing Leading to Potent Inhibition of Orthotopic Glioblastoma
    Weimin Ruan, Sen Xu, Yang An, Yingxue Cui, Yang Liu, Yibin Wang, Muhammad Ismail, Yong Liu, Meng Zheng · 2024 · Advanced Science
80. Stimuli-responsive delivery strategies for controllable gene editing in tumor therapeutics
    Ji Hoon Yu, Liansheng Fan, Suchen Qu, Xin Han · 2022 · Journal of Materials Chemistry B
81. Synthesis and applications of theranostic oligonucleotides carrying multiple fluorine atoms
    Valeri Metelev, Alexei A. Bogdanov Jr · 2020 · Theranostics
82. CRISPR-Cas9 Targeting PCSK9: A Promising Therapeutic Approach for Atherosclerosis
    Bin Gu, Min Li, Dan Li, Kaisen Huang · 2025 · Journal of Cardiovascular Translational Research
83. A multifunctional ‘golden cicada’ nanoplatform breaks the thermoresistance barrier to launch cascade augmented synergistic effects of photothermal/gene therapy
    Wen Yang, Ning Wang, Jin Ping Yang, Chao Liu, Shuang Ma, Xiye Wang, Wenzhen Li, Meiling Shen, Qinjie Wu, Changyang Gong · 2023 · Journal of Nanobiotechnology
84. Engineering redirected NF-κB/OIP5 expression programs to enhance tumor responses to chemotherapy in bladder cancer
    Binbin Zheng, Liman Niu, Haibo Xu, Yubin Yang, Yanping Chen, Chenguang Wang, Wei Chen, Weiren Huang · 2023 · 中国科学通报：英文版
85. Current progress in CRISPR-Cas systems for autoimmune diseases
    Juveriya Israr, Ajay Kumar · 2024 · Progress in molecular biology and translational science
86. CRISPR/Cas bioimaging: From whole body biodistribution to single-cell dynamics
    Ekaterina P. Kolesova, Sabina Pulone, Dmitry S. Kostyushev, Ennio Tasciotti · 2025 · Advanced Drug Delivery Reviews
87. Rationally Designed Peptidyl Virus‐Like Particles Enable Targeted Delivery of Genetic Cargo
    Jia Kong, Yuefei Wang, Jiaxing Zhang, Wei Dong Qi, Rongxin Su, Zhimin He · 2018 · Angewandte Chemie
88. Perfluoroalkyl-containing Compounds as a Tool for Drug Delivery Systems
    Kohsuke Aikawa, Takashi Okazoe · 2022 · Royal Society of Chemistry eBooks
89. Advances in CRISPR/Cas9 Technology for in Vivo Translation
    Yağız Anıl Çiçek, David C. Luther, Jessica A. Kretzmann, Vincent M. Rotello · 2019 · Biological and Pharmaceutical Bulletin
90. RIPK1 regulates cell function and death mediated by UVB radiation and TNF-α
    Yang Zhao, Yao Chen, Xiangsheng Li, Yizhao Sun, Yuxin Shao, Yanfen Zhang, Zhongcheng Liu · 2021 · Molecular Immunology
91. USP9X regulates the proliferation, survival, migration and invasion of gastric cancer cells by stabilizing MTH1
    Wenji Xu, Yaping Zhang, Yingrui Su, Libin Li, Xinxia Yang, Lixing Wang, Hongzhi Gao · 2024 · BMC Gastroenterology
92. Carrier-Free Cellular Transport of CRISPR/Cas9 Ribonucleoprotein for Genome Editing by Cold Atmospheric Plasma
    Haodong Cui, Min Jiang, Wenhua Zhou, Ming Gao, Rui He, Yifan Huang, Paul Kim-Ho Chu, Xue‐Feng Yu · 2021 · Biology
93. Programmable double-unlock nanocomplex self-supplies phenylalanine ammonia-lyase for precise phenylalanine deprivation of tumors
    Chunqing Ou, Meijia Xiao, Xinyue Zheng, Xianzhou Huang, Suleixin Yang, Yingying Leng, Xiaowei Liu, Xiuqi Liang, Linjiang Song, Yanjie You et al. · 2023 · Chinese Chemical Letters
94. CRISPR-Cas9 Delivery by Artificial Virus (RRPHC)
    Suleixin Yang, Qinjie Wu, Yuquan Wei, Changyang Gong · 2019 · Methods in molecular biology
95. Micro‐scale RNA Interference using Iron Oxide Nanoparticle‐modified Lentivirus
    Zi‐Xian Liao, Ivan M. Kempson, Man‐Jing Chen, Yu‐Chen Fa, Kuo‐Yen Huang, Li‐Fang Wang · 2017 · ChemNanoMat
96. Recent Advances in Therapeutic Genome Editing in China
    Yang Yang, Qingnan Wang, Qian Li, Ke Men, Zhiyao He, Hongxin Deng, Weizhi Ji, Yuquan Wei · 2018 · Human Gene Therapy
97. The practical self-targeted oncolytic adenoviral nanosphere based on immuno-obstruction method via polyprotein surface precipitation technique enhances transfection efficiency for virotherapy
    Hao Ran, Guilan Quan, Ying Huang, Chune Zhu, Chao Tsang Lu, Weibin Liu, Xin Pan, Chuanbin Wu · 2018 · Biochemical and Biophysical Research Communications
98. Genome-engineering technologies for modeling and treatment of cystic fibrosis
    Michał Dębczyński, Damian Mojsak, Łukasz Minarowski, Monika Maciejewska, Paweł Lisowski, Robert Marek Mróz · 2023 · Advances in Medical Sciences
99. Aging Genome Modification and Editing using the Crispr-Cas9 system: Anti-Alzheimer Study by Docking Methods
    2022 · Biointerface Research in Applied Chemistry
100. Bioorthogonal Reaction‐Mediated Tumor‐Selective Delivery of CRISPR/Cas9 System for Dual‐Targeted Cancer Immunotherapy
     Jingjing Yang, Kaiyong Yang, Shiyu Du, Wen Luo, Chao Wang, Hongmei Liu, Kunguo Liu, Zhibin Zhang, Yanfeng Gao, Xin Han et al. · 2023 · Angewandte Chemie